Swedish life science demonstration laboratory
GE Healthcare has opened a key technology facility, the GE Healthcare Life Sciences Demonstration Laboratory, at the Science for Life Laboratory in Stockholm, Sweden.
GE Healthcare has opened a key technology facility, the GE Healthcare Life Sciences Demonstration Laboratory, at the Science for Life Laboratory (SciLifeLab) in Stockholm, Sweden. The laboratory, which is equipped with the company’s latest tools and technologies for life sciences research, plans joint research collaborations with SciLifeLab scientists as they seek to understand the latest challenges in human disease.
Mathias Uhlénd, director of SciLifeLab Stockholm, said, "Our vision for SciLifeLab is to create a world-leading centre for molecular biosciences and medical research to foster greater understanding of the nature of human diseases. GE’s Demonstration Laboratory will be a significant and positive addition to the SciLifeLab.”
"The SciLifeLab is assembling a world class multidisciplinary team to study some of medicine’s most pressing problems," said Peter Ehrenheim, retiring CEO of GE Healthcare Life Sciences. “We now know that many of the future advances in medicine will be driven by advances in our understanding of cellular mechanisms at the molecular level. GE Healthcare has a long history of innovation in life sciences, and we are committed to grow in partnership with our customers. The GE Healthcare Life Sciences Demonstration Laboratory will help us to do just that."
The laboratory is equipped with the company’s newest technologies for protein, cell biology and biomedical research. By helping the company gain a deeper understanding into the use of its technologies in a research environment, the laboratory also promises to help drive the future development of new innovations for life sciences research.
For more information about the company visit www.gehealthcare.com
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
Inside the Laboratory –– Women in Separation Science Edition
April 25th 2024Inside the Laboratory is a joint series with LCGC and Spectroscopy, profiling analytical scientists and their research groups at universities all over the world. This series spotlights the current chromatographic and spectroscopic research their groups are conducting, and the importance of their research in analytical chemistry and specific industries. In this “Inside the Laboratory –– Women in Separation Science” special edition PDF, we profile four industry leaders and the impact that their research is having in specific fields such as environmental analysis, forensics, national security, and drug development.
